Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ebetrex 25mg/1.25ml inj pre-filled syringes
1001030U0BFADBP
|
Ebetrex (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Ebetrex 30mg/1.5ml inj pre-filled syringes
1001030U0BFAFBR
|
Ebetrex (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Ebetrex 7.5mg/0.75ml inj pre-filled syringes
1001030U0BFAAAZ
|
Ebetrex (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Jylamvo 2mg/ml oral solution
1001030U0BHAACF
|
Jylamvo | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methofill 27.5mg/0.55ml inj pre-filled injector
1001030U0BGAIBZ
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methofill 27.5mg/0.55ml inj pre-filled syringes
1001030U0BGASBN
|
Methofill (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 10mg/1ml inj pre-filled syringes
1001030U0AABBBB
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 12mg/5ml oral liquid
1001030U0AAASAS
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 15mg/1.5ml inj pre-filled syringes
1001030U0AABCBC
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 15mg/5ml oral liquid
1001030U0AAARAR
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 17.5mg/5ml oral liquid
1001030U0AAATAT
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 18mg/5ml oral liquid
1001030U0AAAXAX
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 1g/40ml solution for injection vials
0801030P0AACTCT
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 1mg/5ml oral liquid
1001030U0AAALAL
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 200mg/8ml solution for injection vials
0801030P0AAASAS
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 20mg/1ml inj pre-filled syringes
1001030U0AABSBS
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 20mg/5ml oral liquid
1001030U0AAAVAV
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 22.5mg/5ml oral liquid
1001030U0AAAYAY
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 25mg/1.25ml inj pre-filled syringes
1001030U0AABPBP
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 25mg/2.5ml inj pre-filled syringes
1001030U0AABDBD
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 25mg/3ml inj pre-filled syringes
0801030P0AAFDFD
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 25mg/5ml oral liquid
1001030U0AAAAAA
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 27.5mg/0.55ml inj pre-filled syringes
1001030U0AABNBN
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Methotrexate 27.5mg/1.1ml inj pre-filled syringes
0801030P0AADRDR
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | No data available |
|
Methotrexate 3.75mg/5ml oral liquid
1001030U0AAAJAJ
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.